VIP

Research Phase

Vasoactive Intestinal Peptide

Aliases
Vasoactive Intestinal Polypeptide, Aviptadil
Administration
Intravenous infusion (studied), Subcutaneous injection (research)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Flushing

A temporary warm, reddened sensation in the skin, typically resolving on its own.

GI effects

General gastrointestinal discomfort, such as nausea or stomach upset.

Injection site reactions

Mild redness, swelling, or discomfort at the site of injection.